Share on StockTwits

Questcor Pharmaceuticals (NASDAQ:QCOR) EVP David Jeffrey Medeiros unloaded 133,541 shares of Questcor Pharmaceuticals stock on the open market in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $64.91, for a total value of $8,668,146.31. Following the completion of the sale, the executive vice president now directly owns 118,051 shares of the company’s stock, valued at approximately $7,662,690. The transaction was disclosed in a document filed with the SEC, which is available at this link.

QCOR has been the subject of a number of recent research reports. Analysts at Mizuho reiterated a “buy” rating on shares of Questcor Pharmaceuticals in a research note to investors on Tuesday, November 26th. Separately, analysts at Zacks upgraded shares of Questcor Pharmaceuticals from a “neutral” rating to an “outperform” rating in a research note to investors on Monday, November 25th. They now have a $70.70 price target on the stock. Finally, analysts at Oppenheimer raised their price target on shares of Questcor Pharmaceuticals from $73.00 to $90.00 in a research note to investors on Wednesday, October 30th. They now have an “outperform” rating on the stock. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $77.27.

Questcor Pharmaceuticals (NASDAQ:QCOR) traded up 1.69% during mid-day trading on Thursday, hitting $64.88. 2,258,306 shares of the company’s stock traded hands. Questcor Pharmaceuticals has a 52 week low of $24.75 and a 52 week high of $74.76. The stock’s 50-day moving average is $54.83 and its 200-day moving average is $59.3. The company has a market cap of $3.821 billion and a price-to-earnings ratio of 14.65.

The company also recently announced a quarterly dividend, which is scheduled for Friday, January 24th. Stockholders of record on Friday, January 17th will be paid a dividend of 0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Wednesday, January 15th.

Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.